Credit Suisse plans Accelerated Return Notes on three biotech stocks

By Wendy Van Sickle

Columbus, Ohio, Feb. 14 – Credit Suisse AG, London Branch plans to price 0% Accelerated Return Notes due April 2018 linked to a basket of three approximately equally weighted biotechnology sector stocks, according to an FWP filing with the Securities and Exchange Commission.

The underlying stocks are Amgen Inc. (33.33% weight), Biogen Inc. (33.34% weight) and Celgene Corp. (33.33% weight).

The payout at maturity will be par plus triple any basket gain, up to a maximum return of 18% to 22%. The exact cap will be set at pricing.

Investors will lose 1% for each 1% decline.

BofA Merrill Lynch is the agent.

The notes will price in February and settle in March.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.